PharmaTalkRadio

PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.

https://www.blogtalkradio.com/pharmatalk

Eine durchschnittliche Folge dieses Podcasts dauert 29m. Bisher sind 534 Folge(n) erschienen. Dieser Podcast erscheint täglich.

Gesamtlänge aller Episoden: 10 days 17 hours 23 minutes

subscribe
share






Current Challenges in Vaccine Delivery and Distribution


Current Challenges in Vaccine Delivery and Distribution


share








 January 23, 2023  29m
 
 

Providing the Right Level of Value to the Patient that Creates Value


Connected Devices: Providing the Right Level of Value to the Patient that Creates Value Back to the Company


share








 January 20, 2023  28m
 
 

Enhancing the Interferon Pathway to Attack Cancer


Enhancing the Interferon Pathway to Attack Cancer – Not a One-Size-Fits-All Approach


share








 January 19, 2023  20m
 
 

Innovative CRISPR-based Editing to Create Off-the-shelf Immune Cell Therapies


Innovative CRISPR-based Editing to Create Off-the-shelf Immune Cell Therapies


share








 January 18, 2023  26m
 
 

Investment Trends in IO


Investment Trends in IO


share








 January 17, 2023  45m
 
 

Investment and Collaboration Strategies in Cell and Gene Therapy


Investment and Collaboration Strategies in Cell and Gene Therapy


share








 January 16, 2023  42m
 
 

Mechanisms of Immune Evasion Mediated by Hypoxia- Inducible Factors


Mechanisms of Immune Evasion Mediated by Hypoxia- Inducible Factors


share








 January 14, 2023  23m
 
 

Neoadjuvant Immune Checkpoint Blockade: A Window into Treatment Response and Pri


Neoadjuvant Immune Checkpoint Blockade: A Window into Treatment Response and Primary Resistance


share








 January 13, 2023  27m
 
 

Regeneron’s Approach to Strategic Collaborations, Licensing and Business Dev.


Regeneron’s Approach to Strategic Collaborations, Licensing and Business Dev.


share








 January 12, 2023  22m
 
 

Panel: Targeted Radiotherapy and the Impact on IO


Panel: Targeted Radiotherapy and the Impact on IO


share








 January 11, 2023  31m